MCK Chart
About

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Distribution Market Cap 115.33B
Enterprise Value 122.38B Income 4.34B Sales 397.96B
Book/sh -10.55 Cash/sh 24.16 Dividend Yield 35.00%
Payout 8.83% Employees 43000 IPO
P/E 26.95 Forward P/E 21.13 PEG
P/S 0.29 P/B -88.54 P/C
EV/EBITDA 20.64 EV/Sales 0.31 Quick Ratio 0.46
Current Ratio 0.88 Debt/Eq LT Debt/Eq
EPS (ttm) 34.67 EPS next Y 44.22 EPS Growth 38.00%
Revenue Growth 11.40% Earnings 2026-05-07 ROA 4.33%
ROE ROIC Gross Margin 3.45%
Oper. Margin 1.54% Profit Margin 1.09% Shs Outstand 122.49M
Shs Float 122.33M Short Float 1.52% Short Ratio 2.25
Short Interest 52W High 999.00 52W Low 635.00
Beta 0.35 Avg Volume 714.35K Volume 329.95K
Target Price $995.27 Recom Buy Prev Close $942.16
Price $934.38 Change -0.83%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$995.27
Mean price target
2. Current target
$934.39
Latest analyst target
3. DCF / Fair value
$1345.88
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$934.39
Low
$860.00
High
$1107.00
Mean
$995.27

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-18 main Barclays Overweight → Overweight $1050
2026-02-10 main JP Morgan Overweight → Overweight $1107
2026-02-05 main TD Cowen Buy → Buy $1012
2026-02-05 main Wells Fargo Equal-Weight → Equal-Weight $925
2026-02-05 main Mizuho Neutral → Neutral $885
2025-12-09 init Barclays — → Overweight $960
2025-11-10 main Wells Fargo Equal-Weight → Equal-Weight $914
2025-11-06 main UBS Buy → Buy $980
2025-11-06 main Baird Outperform → Outperform $927
2025-11-06 main Morgan Stanley Overweight → Overweight $916
2025-10-27 main UBS Buy → Buy $920
2025-10-14 main Jefferies Buy → Buy $900
2025-09-26 main JP Morgan Overweight → Overweight $853
2025-09-24 main Evercore ISI Group Outperform → Outperform $825
2025-09-24 main TD Cowen Buy → Buy $864
2025-09-24 main Citigroup Buy → Buy $860
2025-09-24 main Mizuho Neutral → Neutral $770
2025-09-24 main Morgan Stanley Overweight → Overweight $857
2025-09-24 main Deutsche Bank Buy → Buy $856
2025-09-24 main Wells Fargo Equal-Weight → Equal-Weight $816
Insider Transactions
Date Shares Value Url Text Insider Position Transaction Start Date Ownership
0 2725 2697750.0 Sale at price 990.00 per share. LAU MICHELE Officer 2026-03-02 00:00:00 D
1 349 328013.0 Sale at price 939.86 per share. MARTINEZ MARIA N. Director 2026-02-19 00:00:00 D
2 190 179550.0 Sale at price 945.00 per share. SMITH LEANN B Officer 2026-02-17 00:00:00 D
3 303 282817.0 Sale at price 933.39 per share. LAU MICHELE Officer 2026-02-11 00:00:00 D
4 508 nan SMITH LEANN B Officer 2026-02-10 00:00:00 D
5 4748 nan LAU MICHELE Officer 2026-02-09 00:00:00 D
6 328 313240.0 Sale at price 955.00 per share. RUTLEDGE NAPOLEON B JR Officer 2026-02-06 00:00:00 D
7 276 225266.0 Sale at price 816.18 per share. RODGERS THOMAS L Officer 2026-01-05 00:00:00 D
8 329 283476.0 Sale at price 861.63 per share. RUTLEDGE NAPOLEON B JR Officer 2025-11-07 00:00:00 D
9 11930 8418166.0 Sale at price 705.63 per share. TYLER BRIAN SCOTT Chief Executive Officer 2025-08-22 00:00:00 D
Financials
Line Item2025-03-312024-03-312023-03-312022-03-31
TaxEffectOfUnusualItems-65.73M-46.81M-17.55M-199.65M
TaxRateForCalcs0.200.170.200.33
NormalizedEBITDA5.59B4.96B5.58B3.47B
TotalUnusualItems-327.00M-282.00M-90.00M-605.00M
TotalUnusualItemsExcludingGoodwill-327.00M-282.00M-90.00M-605.00M
NetIncomeFromContinuingOperationNetMinorityInterest3.29B3.00B3.56B1.12B
ReconciledDepreciation636.00M635.00M608.00M760.00M
ReconciledCostOfRevenue345.73B296.12B264.35B250.84B
EBITDA5.26B4.68B5.49B2.87B
EBIT4.62B4.04B4.88B2.11B
NetInterestIncome-92.00M-134.00M-141.00M-168.00M
InterestExpense265.00M252.00M248.00M178.00M
InterestIncome173.00M118.00M107.00M10.00M
NormalizedIncome3.56B3.24B3.64B1.52B
NetIncomeFromContinuingAndDiscontinuedOperation3.29B3.00B3.56B1.11B
TotalExpenses354.24B304.78B272.13B261.37B
TotalOperatingIncomeAsReported4.42B3.91B4.38B2.04B
DilutedAverageShares128.10M134.10M142.20M154.10M
BasicAverageShares127.40M133.20M141.10M152.30M
DilutedEPS25.7222.3925.037.23
BasicEPS25.8622.5425.237.32
DilutedNIAvailtoComStockholders3.29B3.00B3.56B1.11B
NetIncomeCommonStockholders3.29B3.00B3.56B1.11B
NetIncome3.29B3.00B3.56B1.11B
MinorityInterests-186.00M-158.00M-162.00M-173.00M
NetIncomeIncludingNoncontrollingInterests3.48B3.16B3.72B1.29B
NetIncomeDiscontinuousOperations0.000.00-3.00M-5.00M
NetIncomeContinuousOperations3.48B3.16B3.73B1.29B
TaxProvision878.00M629.00M905.00M636.00M
PretaxIncome4.36B3.79B4.63B1.93B
OtherIncomeExpense-365.00M-248.00M189.00M-497.00M
OtherNonOperatingIncomeExpenses-38.00M34.00M279.00M108.00M
SpecialIncomeCharges-394.00M-262.00M-201.00M-746.00M
GainOnSaleOfBusiness0.00
OtherSpecialCharges108.00M147.00M-8.00M465.00M
ImpairmentOfCapitalAssets0.0036.00M69.00M
RestructuringAndMergernAcquisition286.00M115.00M209.00M281.00M
EarningsFromEquityInterest0.000.00
GainOnSaleOfSecurity67.00M-20.00M111.00M141.00M
NetNonOperatingInterestIncomeExpense-92.00M-134.00M-141.00M-168.00M
InterestExpenseNonOperating265.00M252.00M248.00M178.00M
InterestIncomeNonOperating173.00M118.00M107.00M10.00M
OperatingIncome4.82B4.17B4.58B2.59B
OperatingExpense8.51B8.66B7.78B10.54B
SellingGeneralAndAdministration8.51B8.66B7.78B10.54B
GrossProfit13.32B12.83B12.36B13.13B
CostOfRevenue345.73B296.12B264.35B250.84B
TotalRevenue359.05B308.95B276.71B263.97B
OperatingRevenue359.05B308.95B276.71B263.97B
Line Item2025-03-312024-03-312023-03-312022-03-31
TreasurySharesNumber154.00M148.00M141.00M130.00M
OrdinarySharesNumber125.00M130.41M136.00M145.00M
ShareIssued279.00M278.41M277.00M275.00M
NetDebt1.05B916.00M2.35B870.00M
TotalDebt7.39B7.39B7.29B7.54B
TangibleBookValue-13.56B-14.21B-14.08B-13.78B
InvestedCapital3.58B3.66B3.74B3.61B
WorkingCapital-6.21B-4.39B-3.67B-2.23B
NetTangibleAssets-13.56B-14.21B-14.08B-13.78B
CapitalLeaseObligations1.74B1.76B1.70B1.66B
CommonStockEquity-2.07B-1.97B-1.86B-2.27B
TotalCapitalization2.39B3.61B2.77B2.81B
TotalEquityGrossMinorityInterest-1.69B-1.60B-1.49B-1.79B
MinorityInterest380.00M372.00M367.00M480.00M
StockholdersEquity-2.07B-1.97B-1.86B-2.27B
GainsLossesNotAffectingRetainedEarnings-932.00M-881.00M-905.00M-1.53B
OtherEquityAdjustments-932.00M-881.00M-905.00M-1.53B
TreasuryStock27.44B24.12B21.00B17.05B
RetainedEarnings17.92B14.98B12.29B9.03B
AdditionalPaidInCapital8.37B8.05B7.75B7.28B
CapitalStock3.00M3.00M3.00M2.00M
CommonStock3.00M3.00M3.00M2.00M
PreferredStock0.000.000.000.00
TotalLiabilitiesNetMinorityInterest76.83B69.04B63.81B65.09B
TotalNonCurrentLiabilitiesNetMinorityInterest15.23B16.68B15.85B16.62B
OtherNonCurrentLiabilities8.26B8.72B8.44B8.76B
PreferredSecuritiesOutsideStockEquity1.27B
NonCurrentDeferredLiabilities1.03B917.00M1.39B1.42B
NonCurrentDeferredTaxesLiabilities1.03B917.00M1.39B1.42B
LongTermDebtAndCapitalLeaseObligation5.94B7.04B6.03B6.45B
LongTermCapitalLeaseObligation1.48B1.47B1.40B1.37B
LongTermDebt4.46B5.58B4.63B5.08B
CurrentLiabilities61.60B52.36B47.96B48.47B
OtherCurrentLiabilities5.00M4.74B9.00M
CurrentDebtAndCapitalLeaseObligation1.45B345.00M1.27B1.10B
CurrentCapitalLeaseObligation258.00M295.00M299.00M297.00M
CurrentDebt1.19B50.00M968.00M799.00M
OtherCurrentBorrowings1.19B50.00M968.00M799.00M
PayablesAndAccruedExpenses60.16B52.01B46.69B42.63B
CurrentAccruedExpenses4.83B4.92B4.20B4.54B
Payables55.33B47.10B42.49B38.09B
AccountsPayable55.33B47.10B42.49B38.09B
TotalAssets75.14B67.44B62.32B63.30B
TotalNonCurrentAssets19.74B19.47B18.03B17.07B
OtherNonCurrentAssets3.97B3.19B1.99B1.92B
GoodwillAndOtherIntangibleAssets11.49B12.24B12.22B11.51B
OtherIntangibleAssets1.46B2.11B2.28B2.06B
Goodwill10.02B10.13B9.95B9.45B
NetPPE4.28B4.04B3.81B3.64B
AccumulatedDepreciation-2.53B-2.47B-2.23B-1.99B
GrossPPE6.81B6.51B6.04B5.63B
ConstructionInProgress722.00M441.00M283.00M313.00M
OtherProperties1.78B1.73B1.64B1.55B
MachineryFurnitureEquipment2.77B2.75B2.60B2.34B
BuildingsAndImprovements1.43B1.48B1.41B1.33B
LandAndImprovements104.00M109.00M109.00M104.00M
Properties0.000.000.000.00
CurrentAssets55.40B47.97B44.29B46.23B
OtherCurrentAssets1.06B626.00M513.00M898.00M
AssetsHeldForSaleCurrent17.00M4.52B12.00M
PrepaidAssets898.00M665.00M
Inventory23.00B21.14B19.69B18.70B
Receivables25.64B21.62B19.41B18.58B
ReceivablesAdjustmentsAllowances-500.00M-921.00M-158.00M-144.00M
OtherReceivables3.86B3.10B2.41B2.29B
AccountsReceivable22.28B19.44B17.16B16.44B
CashCashEquivalentsAndShortTermInvestments5.69B4.58B4.68B3.53B
CashAndCashEquivalents5.69B4.58B4.68B3.53B
Line Item2025-03-312024-03-312023-03-312022-03-31
FreeCashFlow5.23B3.63B4.60B3.90B
RepurchaseOfCapitalStock-3.15B-3.02B-3.64B-3.52B
RepaymentOfDebt-15.61B-20.90B-9.72B-12.84B
IssuanceOfDebt15.58B20.95B9.45B11.69B
IssuanceOfCapitalStock101.00M116.00M163.00M220.00M
CapitalExpenditure-859.00M-687.00M-558.00M-535.00M
InterestPaidSupplementalData273.00M234.00M224.00M186.00M
IncomeTaxPaidSupplementalData1.12B901.00M562.00M359.00M
EndCashPosition5.69B4.58B4.68B3.53B
OtherCashAdjustmentOutsideChangeinCash-265.00M-2.00M-1.00M-403.00M
BeginningCashPosition4.58B4.68B3.94B6.40B
EffectOfExchangeRateChanges-16.00M6.00M25.00M55.00M
ChangesInCash1.39B-100.00M719.00M-2.52B
OtherCashAdjustmentInsideChangeinCash0.000.00470.00M-540.00M
FinancingCashFlow-3.96B-3.34B-4.37B-6.32B
CashFlowFromContinuingFinancingActivities-3.96B-3.34B-4.37B-6.32B
NetOtherFinancingCharges-554.00M-175.00M-324.00M-1.60B
CashDividendsPaid-345.00M-314.00M-292.00M-277.00M
CommonStockDividendPaid-345.00M-314.00M-292.00M-277.00M
NetCommonStockIssuance-3.04B-2.91B-3.48B-3.30B
CommonStockPayments-3.15B-3.02B-3.64B-3.52B
CommonStockIssuance101.00M116.00M163.00M220.00M
NetIssuancePaymentsOfDebt-21.00M56.00M-277.00M-1.15B
NetShortTermDebtIssuance0.000.000.000.00
ShortTermDebtPayments-15.09B-19.96B-8.45B-11.19B
ShortTermDebtIssuance15.09B19.96B8.45B11.19B
NetLongTermDebtIssuance-21.00M56.00M-277.00M-1.15B
LongTermDebtPayments-519.00M-935.00M-1.27B-1.65B
LongTermDebtIssuance498.00M991.00M997.00M498.00M
InvestingCashFlow-733.00M-1.07B-542.00M-89.00M
CashFlowFromContinuingInvestingActivities-733.00M-1.07B-542.00M-89.00M
NetOtherInvestingChanges-29.00M-160.00M-194.00M-126.00M
NetBusinessPurchaseAndSale155.00M-225.00M210.00M572.00M
SaleOfBusiness179.00M47.00M1.08B578.00M
PurchaseOfBusiness-24.00M-272.00M-867.00M-6.00M
NetIntangiblesPurchaseAndSale-190.00M
PurchaseOfIntangibles-190.00M
NetPPEPurchaseAndSale-537.00M-431.00M-390.00M-388.00M
PurchaseOfPPE-537.00M-431.00M-390.00M-388.00M
CapitalExpenditureReported-322.00M-256.00M-168.00M-147.00M
OperatingCashFlow6.08B4.31B5.16B4.43B
CashFlowFromContinuingOperatingActivities6.08B4.31B5.16B4.43B
ChangeInWorkingCapital1.16B-64.00M384.00M-124.00M
ChangeInOtherWorkingCapital-136.00M331.00M363.00M243.00M
ChangeInOtherCurrentLiabilities-805.00M-734.00M-1.43B-157.00M
ChangeInPayablesAndAccruedExpense8.30B4.59B3.79B2.80B
ChangeInPayable8.30B4.59B3.79B2.80B
ChangeInInventory-2.27B-1.29B-1.26B-1.17B
ChangeInReceivables-3.94B-2.95B-1.08B-1.84B
OtherNonCashItems470.00M341.00M559.00M896.00M
ProvisionandWriteOffofAssets-130.00M819.00M45.00M29.00M
AssetImpairmentCharge98.00M43.00M72.00M175.00M
DeferredTax-110.00M-603.00M-20.00M34.00M
DeferredIncomeTax-110.00M-603.00M-20.00M34.00M
DepreciationAmortizationDepletion636.00M635.00M608.00M760.00M
DepreciationAndAmortization636.00M635.00M608.00M760.00M
AmortizationCashFlow394.00M382.00M360.00M481.00M
AmortizationOfIntangibles394.00M382.00M360.00M481.00M
Depreciation242.00M253.00M248.00M279.00M
OperatingGainsLosses485.00M-17.00M-211.00M1.38B
EarningsLossesFromEquityInvestments0.000.00
GainLossOnSaleOfBusiness485.00M-17.00M-211.00M1.38B
NetIncomeFromContinuingOperations3.48B3.16B3.72B1.29B
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Public Trades for MCK
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status